Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Alterity Therapeutics Ltd. ( (AU:ATH) ) has shared an update.
Alterity Therapeutics Ltd has requested a trading halt for its securities on the ASX, pending an announcement concerning a capital raising initiative. This move, effective immediately, indicates that the company is preparing to make a significant financial announcement that could impact its market operations and potentially influence stakeholder interests. The halt is expected to last until the announcement is made or until normal trading resumes on February 10, 2025.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd is a biotechnology company that focuses on developing therapeutic solutions for neurodegenerative diseases. The company is listed on both the Australian Securities Exchange (ASX: ATH) and the NASDAQ (ATHE).
YTD Price Performance: 0%
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $44.64M
For an in-depth examination of ATH stock, go to TipRanks’ Stock Analysis page.
